Cargando…

HIV and HCV screening by non-infectious diseases physicians: can we improve testing and hidden infection rates?

BACKGROUND: Missed opportunities for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) testing remain high. We aimed to ascertain the knowledge of screening guidelines and attitudes of non-infectious disease (ID) hospital physicians and assess the impact of a 1-h session on screening ra...

Descripción completa

Detalles Bibliográficos
Autores principales:	García-Ruiz de Morales, Alejandro G., Martínez-Sanz, Javier, Vivancos-Gallego, María J., Sánchez-Conde, Matilde, Vélez-Díaz-Pallarés, Manuel, Romero-Hernández, Beatriz, Vázquez, María Dolores González, de Luque, Carmen María Cano, González-Sarria, Ander, Galán, Juan Carlos, Rodríguez, Francisco Gea, Moreno, Santiago, Pérez-Elías, María Jesús
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Public Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332317/ https://www.ncbi.nlm.nih.gov/pubmed/37435522 http://dx.doi.org/10.3389/fpubh.2023.1136988

Ejemplares similares

The Negative Impact of COVID-19 in HCV, HIV, and HPV Surveillance Programs During the Different Pandemic Waves
por: Romero-Hernández, Beatriz, et al.
Publicado: (2022)

Human Monkeypox in People With HIV: Transmission, Clinical Features, and Outcome
por: Vivancos-Gallego, María Jesús, et al.
Publicado: (2022)

Impact of COVID-19 on the Care of Patients with HIV Infection
por: Rosas Cancio-Suárez, Marta, et al.
Publicado: (2023)

An Easy-to-Implement Risk Score for Targeted Hepatitis C Virus Testing in the General Population
por: Martínez-Sanz, Javier, et al.
Publicado: (2022)

MicroRNA Profile of HCV Spontaneous Clarified Individuals, Denotes Previous HCV Infection
por: Brochado-Kith, Óscar, et al.
Publicado: (2019)

High Rates of Hidden HCV Infections among Hospitalized Patients Aged 55–85
por: Piazzolla, Annarita Valeria, et al.
Publicado: (2021)

Outcome of an HIV education program for primary care providers: Screening and late diagnosis rates
por: Martínez Sanz, Javier, et al.
Publicado: (2019)

Beyond patient classification: the “hidden” face of nursing workload
por: de Oliveira, João Lucas Campos, et al.
Publicado: (2022)

Epidemiological trends of HIV/HCV coinfection in Spain, 2015–2019
por: Fanciulli, Chiara, et al.
Publicado: (2022)

MicroRNA signature from extracellular vesicles of HCV/HIV co-infected individuals differs from HCV mono-infected
por: Cairoli, Victoria, et al.
Publicado: (2023)

Impact of storage time in dried blood samples (DBS) and dried plasma samples (DPS) for point-of-care hepatitis C virus (HCV) RNA quantification and HCV core antigen detection
por: Troyano-Hernáez, Paloma, et al.
Publicado: (2023)

Determinants of quality of life and well-being in cognitively unimpaired older adults: a systematic review
por: Frías-Luque, María Dolores, et al.
Publicado: (2022)

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
por: Garbuglia, Anna Rosa, et al.
Publicado: (2014)

Sarcopenia as a Mediator of the Effect of a Gerontogymnastics Program on Cardiorespiratory Fitness of Overweight and Obese Older Women: A Randomized Controlled Trial
por: Marcos-Pardo, Pablo Jorge, et al.
Publicado: (2020)

Telomere Length Increase in HIV/HCV-Coinfected Patients with Cirrhosis after HCV Eradication with Direct-Acting Antivirals (†)
por: Molina-Carrión, Silvia, et al.
Publicado: (2020)

Unraveling the Molecular Mechanisms Involved in HCV-Induced Carcinogenesis
por: Heredia-Torres, Tania Guadalupe, et al.
Publicado: (2022)

Global DNA methylation and telomere length as markers of accelerated aging in people living with HIV and non-alcoholic fatty liver disease
por: Moreno, Elena, et al.
Publicado: (2023)

Prognostic value of liver stiffness in HIV/HCV-Coinfected patients with decompensated cirrhosis
por: Pérez-Latorre, Leire, et al.
Publicado: (2018)

A jumping profile Hidden Markov Model and applications to recombination sites in HIV and HCV genomes
por: Schultz, Anne-Kathrin, et al.
Publicado: (2006)

Patient-to-patient transmission of hepatitis C virus (HCV) during colonoscopy diagnosis
por: González-Candelas, Fernando, et al.
Publicado: (2010)

24-month decline of non-invasive liver fibrosis markers in HCV-mono and HCV/HIV coinfection after direct-acting antiviral therapy
por: Pérez-Is, Laura, et al.
Publicado: (2022)

Correlates of HCV seropositivity among familial contacts of HCV positive patients
por: La Torre, Giuseppe, et al.
Publicado: (2006)

Hidden Cluster Detection for Infectious Disease Control and Quarantine Management
por: Si, Yain-Whar, et al.
Publicado: (2009)

The impact of COVID-19 on surgical training at a tertiary hospital in Greece: a ‘hidden infectious enemy’ for junior surgeons?
por: Vailas, Michail, et al.
Publicado: (2021)

Astraeus: hidden dimensions
por: Phosri, Cherdchai, et al.
Publicado: (2013)

Jejunal gist simulating a uterine myoma: A case report
por: Gonzalez-Vivo, Maria, et al.
Publicado: (2023)

Modifications of liver stiffness and CXCL4, TGF-β1 and HGF are similar in HCV- and HIV/HCV-infected patients after DAAs
por: Márquez-Coello, Mercedes, et al.
Publicado: (2021)

Successful HCV Therapy Reduces Liver Disease Severity and Inflammation Biomarkers in HIV/HCV-Coinfected Patients With Advanced Cirrhosis: A Cohort Study
por: Medrano, Luz Maria, et al.
Publicado: (2021)

Implementation of a lung cancer screening initiative in HIV-infected subjects
por: Díaz-Álvarez, Jorge, et al.
Publicado: (2021)

Surgical excision with left atrial reconstruction of a primary functioning retrocardiac paraganglioma
por: González López, María Teresa, et al.
Publicado: (2013)

Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR
por: Vigón, Lorena, et al.
Publicado: (2019)

Heart Failure after Cardiac Surgery: The Role of Halogenated Agents, Myocardial Conditioning and Oxidative Stress
por: Guerrero-Orriach, José Luis, et al.
Publicado: (2022)

Identification of miRNAs as Biomarkers of Cardiac Protection in Non-Genetically Modified Primary Human Cardiomyocytes Exposed to Halogenated Hypnotics in an In Vitro Model of Transfection and Ischemia/Reperfusion: A New Model in Translational Anesthesia
por: Carmona-Luque, Maria Dolores, et al.
Publicado: (2022)

All‐oral direct‐acting antiviral therapy against hepatitis C virus (HCV) in human immunodeficiency virus/HCV–coinfected subjects in real‐world practice: Madrid coinfection registry findings
por: Berenguer, Juan, et al.
Publicado: (2018)

HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients
por: Brochado-Kith, Óscar, et al.
Publicado: (2021)

Low risk of bacterial co-infection, opportunistic diseases, and persistent immunosuppression in people living with HIV and COVID-19
por: Casado, José L., et al.
Publicado: (2022)

Engaging HIV-HCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients' beliefs (ANRS CO13 HEPAVIH cohort, France)
por: Salmon-Ceron, Dominique, et al.
Publicado: (2012)

The Hidden One: What We Know About Bitter Taste Receptor 39
por: Jalševac, Florijan, et al.
Publicado: (2022)

HBV and HCV Infection in Children and Adolescents
por: Pokorska-Śpiewak, Maria, et al.
Publicado: (2023)

Liver Fibrosis in HCV Monoinfected and HIV/HCV Coinfected Patients: Dysregulation of Matrix Metalloproteinases (MMPs) and Their Tissue Inhibitors TIMPs and Effect of HCV Protease Inhibitors
por: Latronico, Tiziana, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ilh728sbs77mu355hq32dc3pub